(Q40204511)

18 September 2017

TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus (English)

1 reference

18 September 2017

0 references

0 references

1 reference

Raj Priya

1

1 reference

PubMed ID

24905288

18 September 2017

I K Patro

series ordinal

2

1 reference

PubMed ID

24905288

18 September 2017

M M Parida

series ordinal

3

1 reference

18 September 2017

4 June 2014

1 reference

18 September 2017

1 reference

18 September 2017

189

1 reference

18 September 2017

194-205

1 reference

Proteomic analysis of chikungunya virus infected microgial cells

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Neurological complications of Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Characterization of Chikungunya virus infection in human neuroblastoma SH-SY5Y cells: role of apoptosis in neuronal cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Peroxisomes are signaling platforms for antiviral innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

[Chikungunya in paediatrics: epidemic of 2005-2006 in Saint-Denis, Reunion Island]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The role of antibody in recovery from alphavirus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Molecular and serological diagnosis of Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Noncytolytic control of viral infections by the innate and adaptive immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Mouse Mx2 protein inhibits hantavirus but not influenza virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Synergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Production, characterization, and application of monoclonal antibodies specific to recombinant (E2) structural protein in antigen-capture ELISA for clinical diagnosis of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The earliest manifestation of focal encephalitis on diffusion-weighted MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Possible mechanisms for the transport of Semliki forest virus into and within mouse brain. An electron-microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Chikungunya, an epidemic arbovirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Isolation and Persistence of Chikungunya Virus in Cultures of Mouse Brain Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Neurologic manifestations of pediatric chikungunya infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Comparative full genome analysis revealed E1: A226V shift in 2007 Indian Chikungunya virus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

A diverse range of gene products are effectors of the type I interferon antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

[Neurological manifestations in Chikungunya: about 23 cases collected in Reunion Island].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Virus isolation as one of the diagnostic methods for dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

TLR3 deficiency in patients with herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

10.1016/J.VIRUSRES.2014.05.010

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

24905288